Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors
Samarth Hegde(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Benoit Kloeckner(Inserm), Juliana J. Lee(Harvard University), Leanna Troncoso(Icahn School of Medicine at Mount Sinai), Theodore Chin(California Institute of Technology), Assaf Magen(Icahn School of Medicine at Mount Sinai), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Darwin D’souza(Icahn School of Medicine at Mount Sinai), Michael J. Bale(Cornell University), László Halász(Johns Hopkins University), Florent Ginhoux(SingHealth), Bruno Giotti(Icahn School of Medicine at Mount Sinai), Brian Y. Soong(Icahn School of Medicine at Mount Sinai), Jessica Le Bérichel(Icahn School of Medicine at Mount Sinai), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Raja M. Flores(Icahn School of Medicine at Mount Sinai), Grace Chung(Icahn School of Medicine at Mount Sinai), Dughan Ahimovic(Cornell University), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Alexander M. Tsankov(Icahn School of Medicine at Mount Sinai), Meriem Belabed(Icahn School of Medicine at Mount Sinai), Travis Dawson(Icahn School of Medicine at Mount Sinai), Krista Angeliadis(Icahn School of Medicine at Mount Sinai), Sai Ma(Foshan University), Adam Marks(Icahn School of Medicine at Mount Sinai), Andrew Kaufman(Columbia University), Raphaël Mattiuz(Icahn School of Medicine at Mount Sinai), Steven Z. Josefowicz(Cornell University), Pauline Hamon(Icahn School of Medicine at Mount Sinai)
Cited by 8
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k